GeneDx Holdings Corp. (WGS)
68.53
-2.99
(-4.18%)
USD |
NASDAQ |
Oct 07, 16:00
68.48
-0.05
(-0.07%)
After-Hours: 20:00
GeneDx Holdings Gross Profit Margin (Quarterly) : 64.05% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.05% |
| March 31, 2026 | 61.48% |
| December 31, 2025 | 65.23% |
| September 30, 2025 | 68.04% |
| June 30, 2025 | 64.37% |
| March 31, 2025 | 65.87% |
| December 31, 2024 | 64.38% |
| September 30, 2024 | 56.45% |
| June 30, 2024 | 54.66% |
| March 31, 2024 | 52.83% |
| December 31, 2023 | 44.54% |
| September 30, 2023 | 34.14% |
| Date | Value |
|---|---|
| June 30, 2023 | 19.83% |
| March 31, 2023 | 16.66% |
| December 31, 2022 | -49.58% |
| September 30, 2022 | 9.92% |
| June 30, 2022 | -97.35% |
| March 31, 2022 | 4.89% |
| December 31, 2021 | -9.22% |
| September 30, 2021 | -23.44% |
| June 30, 2021 | -5.73% |
| March 31, 2021 | -9.61% |
| December 31, 2020 | -9.40% |
| September 30, 2020 | 2.57% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | 52.76% |
| CS Diagnostics Corp. | -- |
| Aibotics, Inc. | -- |
| Intellia Therapeutics, Inc. | 72.58% |
| 10X Genomics, Inc. | 74.36% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.65% |
| Return on Assets | -21.14% |
| Return on Invested Capital | -25.88% |
| Profit Margin (Quarterly) | -15.50% |
| Operating Margin (Quarterly) | -12.37% |
| Return on Net Operating Assets | -31.72% |